• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Ascendia Pharmaceuticals Poised for Expansion

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Emergent BioSolutions

    Almac Group

    Alcami

    Adare Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Emergent BioSolutions

    Syngene

    Almac Group

    Aphena Pharma Solutions

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Top 5 Things to Know Before Selecting Clinical Trial Technology

    Look for a future-proof model, innovative vendors - not cutting-edge technology, and focus on user-centered design and interoperability.

    Top 5 Things to Know Before Selecting Clinical Trial Technology
    Related CONTENT
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
    • Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    • Recro Pharma Expands Business Development Team
    • LabVantage Solutions Expands and Improves its Portfolio
    Andres Garcia, Co-founder and CTO Florence02.08.21
    Technology is only useful when it is in the service of people. This concept is by no means earth-shattering, but it is a fundamental truth that, surprisingly, is ignored by many vendors and technologists.
     
    Technology can be a powerful enabler that has permitted industries to create significant progress at record speeds, but it can also be a source of incredible frustration. 
     
    Let’s take a look at clinical trials, or for that matter, healthcare. Advancements areseen every day in healthcare. So, why is it that technology also gets in the way of the day-to-day? Particularly when it comes to caring for patients, developing a next new vaccine, cure or treatment through clinical research.
     
    There are five key elements to consider when selecting technology for clinical research to create a cohesive experience for teams, patients, and stakeholders.
     

    1.  Select technology that has a future-proof model.

    Building technology is a challenging task. Like every other practice, vendors can do it well, or they can do it poorly. And as the buyer, you need to know if your vendor will scale as you scale with the industry. 
     
    Asking your vendor if they built a “future-proof” technology is of no use. Their answer will always be yes. Instead, you need to look at the evidence in their technology and processes that may reveal the answer.
     
    Here are some examples of what to look at when evaluating your vendor:

    ·      How many versions of the software are currently supported and in use by existing customers?
    If many versions exist, the software may be difficult, costly or risky to upgrade. On the other hand, if most customers are using the latest two versions of the software, the vendor likely has a practical strategy to support both organizational growth and the software evolution.
    ·      Does the technology integrate easily with other systems?
    Vendors should not build software in a silo. There should be open, well-documented, and easy to understand ways to integrate with other systems, whether it is APIs or data protocols to exchange data. Effective software for clinical research should not live entirely on its own. Instead, it should be a specific tool in a toolset that operates as part of a larger ecosystem.  Without system integrations, technology will not “talk” to or “work with” current technology or future platforms.
    ·      Can the vendor incorporate your needs into the evolution of the software?
    No software is perfect. Organizations will find opportunities to solve additional problems or change how certain features work. The vendor’s willingness to incorporate suggestions into future product updates may partially dictate your satisfaction with the software. Determine if there is a way to provide meaningful input. Some feedback opportunities to look for include product office hours, account manager meetings, product feedback forums or in-app satisfaction surveys. Go into a software purchase with complete clarity on if and how customer feedback is incorporated.
     

    2. Find a vendor with a team you can trust.

    When buying software, you are creating a relationship between your organization and the vendor. Every single aspect of the experience – the software, onboarding, customer support and potential challenges – will all be laced with the vendor’s company culture.
     
    The people behind the technology will dictate your overall satisfaction. Some questions to help you investigate:
    ·      Do you mesh well with the team members you have engaged with at the company?
    ·      Does customer service prioritize the company’s interests before the customers’?
    ·      Does the sales team feel disingenuous? Do they answer your requests on time?
    ·      Is the marketing messaging gimmicky?
    ·      Does the company have thought leaders in the industry? Do they have a mission you believe in?
     
    An unauthentic company reflects on the quality of their products. Not many companies can survive with the brilliant jerk culture or the cut-throat management culture without it permeating into their products. Maybe it is not evident at the moment, but it will likely show up down the road.
     

    3.  Look for innovative vendors, not cutting-edge technology.

    Cutting-edge technology may not always be the best answer to your needs. Being an early adopter of a brand-new technology creates great opportunity but also great risk.
     
    Instead, consider focusing your efforts on the innovative nature of the vendor rather than the shiny bells and whistles of the technology.
     
    Innovation happens on established and proved technology. An innovative vendor is much more valuable than leading-edge technology because they can adapt and evolve with the industry's needs. Innovation is manifested in processes, flexibility and stability of solutions and responsiveness to your needs.
     

    4. Focus on user-centered design that is visible and evident.

    Health care, especially clinical research, has historically had a limited number of technology options available. Many companies in this space have been busy creating functional technology without focusing on how easy or intuitive it is to use. These vendors are only interested in creating intriguing software to sell to high-level executives and disregard the ease-of-use for lower-level team members who will be using the software daily.
     
    Technology that isn’t easy to use or intuitive has major hidden costs down the road: slow training and onboarding, low rates of site or user adoption, high levels of user errors, employee dissatisfaction and higher risk for audit findings.
     
    A vendor that values their users will reflect this in user-centric design, ease-of-use, accessibility to users with disabilities, interoperability, reportability and customer support. 
     

    5.  Ensure capabilities for two-way integrations.

    Interoperability is an important aspect of any software solution. But one very important distinction is that the technology needs the ability to have two-way integrations with other systems.
     
    Two-way integrations are an advanced topic and rarely discussed among people without technical backgrounds, but this is an important factor to consider.
     
    Software applications can usually communicate with one another by “exposing” what is called API endpoints; that is, functions that can be invoked by an external system. For example, in a document management system, an external system can programmatically upload a document by invoking one of these endpoints.  
     
    Many vendors tout the interoperability of their solution by showing the myriad of interfaces and APIs they expose. This usually means that external systems can use the solution to perform inbound actions, which is helpful. 
     
    However, the solution also must allow outbound interfaces to run. Consider asking the following:
    ·      Can the solution notify other systems of actions or events that are taking place in it? 
    ·      Can the solution push commands or notifications to other systems?
     
    If the answer is yes and the vendor provides both inbound and outbound interfaces, you will have a good chance at integrating this solution with your current or future technologies. If the answer is no, be aware that someone in the IT department, or a consultant, will have to create complex solutions to integrate this software with others, most likely at a high cost.


    Andres Garcia is Co-Founder and CTO of Florence Healthcare, an organization focused on improving clinical trials by building technology that helps research sites, CROs and sponsors streamline complex processes and workflows. Before co-founding Florence, he served as Product Manager for AirWatch prior to its $1.5B acquisition by VMware. His experience in security technology coincides with his passion for solving problems with technology, and he believes culture is the most important aspect of a company.
    Related Searches
    • Information Technology
    • Clinical Trials
    Suggested For You
    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
    Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
    Recro Pharma Expands Business Development Team Recro Pharma Expands Business Development Team
    LabVantage Solutions Expands and Improves its Portfolio LabVantage Solutions Expands and Improves its Portfolio
    RBQM Comes of Age: COVID as a Catalyst for Change RBQM Comes of Age: COVID as a Catalyst for Change
    Steriline Delivers New Manufacturing Line to Bess Pro Steriline Delivers New Manufacturing Line to Bess Pro
    Vibalogics Updates U.S. Leadership Team Vibalogics Updates U.S. Leadership Team
    Advanced Analytics Advancing Development of Genetic Vaccines Advanced Analytics Advancing Development of Genetic Vaccines
    EMA Approves BioNTech EMA Approves BioNTech's COVID Vax Production at Marburg Site
    CyanVac and Exothera Enter COVID-19 Vaccine Partnership CyanVac and Exothera Enter COVID-19 Vaccine Partnership
    BioCentriq, Kytopen Enter Cell Therapy Alliance BioCentriq, Kytopen Enter Cell Therapy Alliance
    JSR Life Sciences Unveils Corporate Venture Fund JSR Life Sciences Unveils Corporate Venture Fund
    Piramal Pharma Solutions, Plus Therapeutics Ink MSA 
 Piramal Pharma Solutions, Plus Therapeutics Ink MSA 

    BioCentriq and Kytopen Enter Cell Therapy Partnership BioCentriq and Kytopen Enter Cell Therapy Partnership

    Related Expert's Opinion

    • Clinical Trials | Drug Development
      Regulatory Practices in a Post-Pandemic World

      Regulatory Practices in a Post-Pandemic World

      Envisioning the new normal for clinical development.
      Dr. Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 03.22.21

    • Clinical Trials | Information Technology
      The Evolution of Clinical Research Technology to Support Remote Collaboration

      The Evolution of Clinical Research Technology to Support Remote Collaboration

      Pioneering change with technology advancements that yield high reward with tolerable risk.
      Angela Gill Nelms, COO for Florence Healthcare 03.11.21

    • Clinical Trials | Information Technology
      Data Management Trends

      Data Management Trends

      Pandemic-fueled patient centricity is creating new challenges and opportunities for data management teams.
      Deepu Joseph, Global Head & VP of Clinical Data Management 03.05.21


    • Clinical Trials
      The Future of Clinical Trials Series: Part II

      The Future of Clinical Trials Series: Part II

      Greater awareness will ensure diversity is no longer an afterthought and patients will be at the center of every aspect of clinical research.
      Jena Daniels, Rasmus Hogreffe, Ingrid Oakley-Girvan, Dr. Michelle Longmire, Medable 01.26.21

    • Clinical Trials
      The Future of Clinical Trials Series: Part I

      The Future of Clinical Trials Series: Part I

      What will 2021 have in store for an industry in flux?
      Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Vice President of Decentralized Solutions, Syneos Health 01.19.21

    • Clinical Trials | Drug Development | Information Technology
      Virtual Clinical Trials: The Future of Dermatology Studies

      Virtual Clinical Trials: The Future of Dermatology Studies

      COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.
      Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21


    • Clinical Trials | Drug Development
      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs

      Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.
      Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21

    • Clinical Trials | Information Technology
      Life Sciences Strive for Greater Agility

      Life Sciences Strive for Greater Agility

      Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.
      Ronan Brown, SVP of Integrated Technology & Compliance, and Joe Rymsza, VP, Global PV & Regulatory Technology Solutions, IQVIA 12.14.20

    • Clinical Trials | Drug Development | Information Technology
      Advances in Intelligent Automation

      Advances in Intelligent Automation

      The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.
      Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20


    • Information Technology | Supply Chain
      The Pandemic & The Pharma Industry: 3 Things to Know

      The Pandemic & The Pharma Industry: 3 Things to Know

      The importance of vendor contract visibility, an increase in intense legal scrutiny, and new technology for greater agility and control.
      Colin Earl, CTO at Agiloft 11.16.20

    • Clinical Trials | Information Technology
      AI and Advanced Analytics

      AI and Advanced Analytics

      Equipped with the right tools, CROs are better positioned to develop optimal protocols, rapidly identify patients to enroll, and preempt study issues.
      Paul Oliver, Medidata 11.13.20

    • Clinical Trials | Information Technology
      eCOA: Addressing Barriers to Faster Deployment in Clinical Trials

      eCOA: Addressing Barriers to Faster Deployment in Clinical Trials

      Clinical Outcome Assessments are an increasingly important tool in clinical research.
      Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata 11.13.20


    • Clinical Trials | Information Technology
      Adding Remote Site Access to Sponsor Bids: What to Know as CRO

      Adding Remote Site Access to Sponsor Bids: What to Know as CRO

      Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.
      Ryan Jones, CEO, Florence Healthcare 10.13.20

    • Clinical Trials | Drug Development
      How to Balance Internal and External Staff Within Outsourcing Models

      How to Balance Internal and External Staff Within Outsourcing Models

      Strategies to consider in flexed staffing models.
      John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD 09.22.20

    • Clinical Trials | Drug Development
      FDA Response to COVID-19

      FDA Response to COVID-19

      A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.
      Jack Modell, M.D., Vice President and Senior Medical Officer, Rho 09.03.20

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Ascendia Pharmaceuticals Poised For Expansion
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login